BD announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY investigational device exemption (IDE) ...

Johnson & Johnson MedTech announced 1-year results from the DISRUPT BTK II postmarket study, demonstrating sustained safety ...

Amplitude Vascular Systems (AVS) announced results from the first 95 patients treated in the POWER PAD II United States ...

Penumbra, Inc. announced that results of the STORM-PE randomized controlled trial (RCT) were presented at VIVA 2025, the Vascul ...

Contego Medical announced 30-day outcomes from the PERFORMANCE III study evaluating the Neuroguard IEP system for direct transc ...

Endovascular Engineering, Inc. (E2) announced positive results from the pivotal cohort of the ENGULF investigational device exe ...

Egg Medical, Inc. announced the presentation of real-world studies demonstrating that the company’s EggNest Complete radi ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.